Affiliation:
1. Military Medical Academy named after S.M. Kirov
Abstract
Aim. In this study we retrospectively evaluated the clinical effectiveness and safety of nucleoside analogues (Triazavirin© and ribavirin) with that of oseltamivir for treating moderate severe influenza in adults. Materials and methods. We have used data from 191 health records of patients with moderate severe PCR confirmed influenza A and B. Control group included 57 patients treated with oseltamivir, comparison groups – 53 and 81 patients, who received Triazavirin© and ribavirin accordingly. We compared infectious intoxication syndrome duration, fever duration, duration of acute rhinitis, acute pharyngitis, acute laryngitis, acute tracheitis, acute bronchitis, cough duration as well as pneumonia occurrence. Results. No statistically significant difference in the duration of developed syndromes in Triazavirin©-treated group and oseltamivir-treated group were observed. We have noticed that fever duration had been significantly longer in ribavirin group compared to control group (4,1±2,22 days vs. 3,1±1,94 days, p<0,05) as well as more frequent pneumonia occurrence (1,2% vs. 0,0%, p>0,05). Conclusion. New nucleoside analogue Triazavirin© showed good efficacy and safety profile in adult patients with influenza. This fact provides the opportunity to recommend it for treatment of influenza along with neuraminidase inhibitors.
Reference31 articles.
1. Lvov N.I. et al. Zhurnal infektologii. 2014; 6 (3): P.62–79 (in Russian).
2. Influenza virus infections in humans October 2018 [Internet]. – Available from: http://www.who.int/influenza/human_animal_interface/virology_laboratories_and_vaccines/influenza_virus_infections_humans _Oct_18.pdf. – (cited 12.11.2018).
3. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro / J.T. Nguyen [et al.] // PLoS One. – 2010. – №5 (22). – Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009332 – (cited 12.11.2018).
4. Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms / S. Boivin [et al.] // The Journal of biological chemistry. – 2010. – №285 (37). – P.28411-28417.
5. Stevaert, A. The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design / A. Stevaert, L. Naesens // Medicinal research reviews. – 2016. – №36 (6). – P. 1127-1173.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献